Recently, Newsweek featured Hadassah’s Sharett Institute of Oncology among the best medical centers in the world – the only medical center in Israel that made it into their ranking.
Since anti-PD1 is the leading immunotherapy treatment in cancer patients, such an achievement can impact the quality of life of thousands of cancer patients worldwide every day.
Kyle Limper, 16, from Philadelphia, was a normal and active teenage boy who played several sports. After suffering from severe back pain, he went to a local hospital to find the cause.
An experimental treatment developed at Israel's Hadassah-University Medical Center has a 90% success rate at bringing patients with multiple myeloma into remission.
Ovarian cancer isn't considered common, but in many cases it's fatal. Due to vague symptoms, this cancer is usually diagnosed at an advanced stage and is hard to treat.
Shir for Life wants to advance groundbreaking research and is thus kickstarting a crowdfunding campaign today to reach this goal.
The study showed that mutations in the MUTYH gene associated with the hereditary MAP syndrome cause about 27% of the cases of polyposis patients.
RNA-based nanodrugs show an 80% survival rate of the female reproductive system impacting cancer.
The results add data details to partial findings released by the companies in December.
ATF4, previously thought to be an indicator of advanced-stage liver cancer, may hold the key to its prevention and treatment.
JPOST Digital Library
